NCT04042571View on ClinicalTrials.gov

Permanent Cerebral Oxymetry Monitoring for Early Diagnosis and Treatment of Delayed Vasospasm After Subarachnoid Hemorrhage

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 1, 2019

Primary Completion Date

December 24, 2022

Study Completion Date

December 30, 2022

Conditions
Subarachnoid Hemorrhage
Interventions
DEVICE

Cerebral oxymetry monitoring (NIRS)

Near-InfraRed Spectroscopy (NIRS) is a non-invasive method measuring tissue oxygenation by regional saturation of capillary-oxygenated hemoglobin (rSO2). Starting on day 4 after aneurismal rupture NIRS electrods will be placed and maintained until day 12 permanently and blindly recording rSO2. Patients will be monitored following daily practice recommandations inclunding vasospasm detection and treatment.

Trial Locations (1)

33 076

CHU de Bordeaux, Bordeaux

All Listed Sponsors
lead

University Hospital, Bordeaux

OTHER

NCT04042571 - Permanent Cerebral Oxymetry Monitoring for Early Diagnosis and Treatment of Delayed Vasospasm After Subarachnoid Hemorrhage | Biotech Hunter | Biotech Hunter